EugeneLitMD

Ophthalmology • Oakland, CA

Retinal Disease, Uveitis

Partner at East Bay Retina Consultants, Inc.

Join to view full profile

Dr. Lit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lit's full profile

Already have an account?

Office
3300 Telegraph Ave
Oakland, CA 94609
Phone+1 510-444-1600

Fax+1 510-444-5117
Is this information wrong?

Summary

Dr. Lit graduated Cum Laude from Harvard Medical School after graduating with Honors from the California Institute of Technology (Caltech), majoring in molecular biology and minoring in organic chemistry. He went on to receive his Ophthalmology residency and retina training at the Massachusetts Eye and Ear Infirmary, Harvard Medical School, where he also served as the Director of Eye Trauma and was an Associate Chief of Ophthalmology. He is Board-certified in Ophthalmology, has lectured and taught at the University of California, San Francisco, and is a Fellow of the American Academy of Ophthalmology. In addition to publishing numerous peer-reviewed scientific articles, Dr. Lit has also authored and edited various medical textbook chapters and journals. His current research interests include clinical trials of new intravitreal drugs for macular degeneration, surgical treatment of retinal diseases, age-related macular degeneration, as well as novel treatments for retinal vascular disease and diabetic retinopathy.

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2000 - 2002
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1996 - 2000
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1996 - 1999
Mount Auburn HospitalInternship, Internal Medicine, 1995 - 1996
Harvard Medical SchoolClass of 1995

Certifications & Licensure

CA State Medical License 2002 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Harvard Medical School National Scholarship Harvard Medical School
California Institute of Technology Academic Merit Scholarship California Institute of Technology
Academic Award Chinese-American Engineers and Scientists Association of Southern California
Chinese-American Faculty Association Scholarship Chinese-American Faculty Association
Ethel Hazel Allen Scholarship
Ontario Scholar
Kiwanis Piano Scholarship
Margherio Award Retina Society, 2002
Cum Laude, Doctor of Medicine Harvard Medical School, Boston, MA, 1995
College Honors, Bachelors of Science California Institute of Technology, Pasadena, CA, 1991
1st Place Research Award, Southern California Undergraduate Research Conference American Chemical Society, 1990
Top MD Consumers Checkbook
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) Start of enrollment: 2007 Jun 01
Completed
Phase 3
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) Start of enrollment: 2007 Jul 01
Completed
Phase 3
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Start of enrollment: 2007 Aug 01
Completed
Phase 3
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Start of enrollment: 2009 Jul 01
Completed
Phase 3
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
Completed
Phase 2
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion Start of enrollment: 2009 Aug 01
Unknown status
Phase 2
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion Start of enrollment: 2010 Aug 01
Completed
Phase 3
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography Start of enrollment: 2010 Nov 01
Completed
Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) Start of enrollment: 2011 Jan 01
Completed
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema Start of enrollment: 2011 May 01
Completed
Phase 3
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Start of enrollment: 2014 Sep 01
Completed
Phase 3
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
Terminated
Phase 3
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
Completed
Phase 3
Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration Start of enrollment: 2015 Jun 25
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun J...> ;JAMA Ophthalmol. 2016 Feb
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
Do DV, Sepah YJ, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus DM, Halperin L, Sadiq MA, Rajagopalan N, Campochiaro PA, Nguyen QD> ;Eye (Lond). 2015 Dec
Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab.
Channa R Sophie R Khwaja AA Do DV Hafiz G Nguyen QD Campochiaro PA> ;Eye (Lond). 2014 Mar
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.
Do DV Nguyen QD Khwaja AA Channa R Sepah YJ Sophie R Hafiz G Campochiaro PA> ;JAMA Ophthalmol. 2013 Feb
Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.
Loftus JV, Sultan MB, Pleil AM> ;Invest Ophthalmol Vis Sci. 2011 Sep
A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.
Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS> ;Ophthalmology. 2011 Jun
394 citations
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja, Roomasa Channa, Elham Hatef, Diana V. Do, David S. Boyer, Jeffery S. Heier, Prema Abraham, Allen B. Thach, Eugene ...> ;Ophthalmology. 2010 Nov 1
18 citations
Topical Mecamylamine for Diabetic Macular Edema
Peter A. Campochiaro, Syed Mahmood Shah, Gulnar Hafiz, Jeffery S. Heier, Eugene S. Lit, Ingrid Zimmer-Galler, Roomasa Channa, Quan Dong Nguyen, Beena Syed, Diana V. Do...> ;American Journal of Ophthalmology. 2010 May 1
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
Nguyen QD Shah SM Heier JS Do DV Lim J Boyer D Abraham P Campochiaro PA> ;Ophthalmology. 2009 Nov
6 citations
Lamina puncture for central retinal vein occlusion: results of a pilot trial.
Donald J. D'Amico, Eugene S. Lit, Francesco Viola> ;Archives of Ophthalmology. 2006 Jul 1
22 citations
Retinal Microvascular Surgery: A Feasibility Study
Miltiadis K. Tsilimbaris, Eugene S. Lit, Donald J. D'Amico> ;Investigative Ophthalmology & Visual Science. 2004 Jun 1
In vivo rabbit eyecup preparation for use in retinal research.
Miltiadis K. Tsilimbaris, Eugene S. Lit, John B. Christoforidis, Donald J. D'Amico> ;Investigative Ophthalmology & Visual Science. 2004 Mar 1
24 citations
Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion.
Eugene S. Lit, Miltiadis K. Tsilimbaris, Eustratios V. Gotzaridis, Donald J. D'Amico> ;Archives of Ophthalmology. 2002 Apr 1
32 citations
Anterior and posterior segment intraocular foreign bodies.
Eugene S. Lit, Lucy H. Young> ;International Ophthalmology Clinics. 2002 Jan 1
7 citations
Progress in vitreoretinal surgery for proliferative diabetic retinopathy.
Eustratios V. Gotzaridis, Eugene S. Lit, Donald J. D'Amico> ;Seminars in Ophthalmology. 2001 Mar 1
15 citations
Retinal manifestations of morning glory disc syndrome.
Eugene S. Lit, Donald J. D'Amico> ;International Ophthalmology Clinics. 2001 Jan 1
20 citations
Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients.
Eugene S. Lit, Rosa Y. Kim, Donald J. D'Amico> ;Retina. 2001 Jan 1
Join now to see all

Journal Articles

Pediatric Ophthalmology - A Subspecialty Perspective
Lit ES, Azar N, Jakobiec FA, Int Ophthalmol Clin, 2002
Conformational Changes of Butanedioic Acid as a Function of pH as Determined from Changes in Vicinal Proton-Proton NMR Couplings.
Lit ES, Mallon FK, Tsai HY, Roberts JD, J Amer Chem Soc, 1993

Books/Book Chapters

The Complicated Cataract; The MEEI Phacoemulsification Practice Handbook
Chapter: The Traumatic Cataract
Lit ES, Pineda REditors: Pineda R, Espaillit A, Perez V, Rowe S.Slack, New Jersey2001

Abstracts/Posters

Feasibility of Lamina Cribosa Surgery for Central Retinal Vein Occlusion
Lit ES, Gotzaridis S, D'Amico DJ, Association for Research in Vision and Ophthalmology, 2001
Staining of the Retina with Biological Dyes; A Useful Tool in Non-contact Surgery using Erbium YAG Laser to Ablate the ILM
Gotzaridis EV, Lit ES, D'Amico DJ, Aegean Retina, 2001
Lamina Cribosa Surgery for Central Retinal Vein Occlusion
D’Amico DJ, Lit, ES, Gotzaridis EV, Aegean Retina, 2001
Prognostic Factors for Determining Final Visual Acuity and Need for Retinal Surgery in Open Globe Injuries
Sippel KC, Arroyo JG, Sharma A, Lit ES, The Association for Research in Vision and Ophthalmology, 2000
Endophthalmitis Following Cataract Surgery
Chao CW, Henderson BA, Lit ES, The Association for Research in Vision and Ophthalmology, 2000
Use of Retrobulbar Chlorpromazine Versus Alcohol in the Treatment of Blind Painful Eyes
Yuen SA, Lit ES, Chen TC, The Association for Research in Vision and Ophthalmology, 2000
. Endophthalmitis in clear cornea vs. scleral tunnel phacoemulsification
Lit ES, Cherry JJ, Henderson BA, The Association for Research in Vision and Ophthalmology, 1999
Adequacy of Diabetic Retinopathy Screening in Type II Diabetics
Lit ES, The Association for Research in Vision and Ophthalmology, 1998
Join now to see all

Committees

Massachusetts Eye Ear Infirmary, Harvard Medical School, Fellowship Steering Committee 2001 - 2002
Massachusetts Eye Ear Infirmary, Harvard Medical School, Graduate Medical School Education Committee 1999 - 2000
Massachusetts Eye Ear Infirmary, Harvard Medical School, Resident Admission Selection Committee 1999 - 2000
Massachusetts Eye Ear Infirmary, Harvard Medical School, Resident Steering Committee 1998 - 2000
Massachusetts Eye Ear Infirmary, Harvard Medical School, Executive Selection Committee - Mead Memorial Lectureship